Annals of the New York Academy of Sciences

Circulating Nucleic Acids and Critical Illness

TIMOTHY H. RAINER

Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Search for more papers by this author

NICOLE Y.L. LAM,

NICOLE Y.L. LAM

Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Search for more papers by this author

TIMOTHY H. RAINER,

TIMOTHY H. RAINER

Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Search for more papers by this author

NICOLE Y.L. LAM,

NICOLE Y.L. LAM

Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Search for more papers by this author

First published: 05 September 2006

https://doi.org/10.1196/annals.1368.035

Citations: 32

Address for correspondence: Dr. T. H. Rainer, Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR. Voice: +852-2632-1033; fax: +852-2648 -1469.
e-mail: [email protected]

Share a link

Email
Facebook
Twitter
LinkedIn
Reddit
Wechat

Abstract

Abstract: This article reviews some of the early work that has been performed to investigate the potential roles of circulating nucleic acids as prediction markers in acute illness and injury. Circulating DNA and RNA concentrations are elevated early in patients with trauma, stroke and ACS, and are generally highest in patients with a high risk of death. Circulating nucleic acids may be useful markers for the evaluation and risk-stratification of such patients.

REFERENCES

1 Murray, C.J.L. & A.D. Lopez. 1997. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349: 1269–1276.
2 Sauaia, A. et al. 1998. Multiple organ failure can be predicted as early as 12 hours after injury. J. Trauma 45: 291–303.
3 Steg, P.G. et al. 2003. Comparison of angioplasty and pre-hospital thrombolysis in acute myocardial infarction (CAPTIM) investigators. Circulation 108: 2851–2856.
4 Albers, G.W. et al. 2002. SA. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase thrombolysis for acute non-interventional therapy in ischemic stroke. Stroke 33: 493–495.
5 Lo, Y.M.D. et al. 2000. Plasma DNA as a prognostic marker in trauma patients. Clin. Chem. 46: 319–323.
6 Wittwer, C.T. et al. 1997. The LightCycler: a microvolume multi sample fluorimeter with rapid temperature control. BioTechniques 22: 176–181.
7 Murray, C.J.L. & A.D. Lopez. 1997. Alternative projections of mortality and disability by cause 1990–2020: global burden of diseases study. Lancet 349: 1498–1505.
8 Moore, F.A. et al. 1996. Post injury multiple organ failure: a bimodal phenomenon. J. Trauma 40: 501–510.
9 Rainer, T. et al. 2001. Derivation of a prediction rule for posttraumatic organ failure using. Ann. N. Y. Acad. Sci. 945: 211–220.
10 Jahr, S. et al. 2001. DNA fragments in the blood plasma of cancer patients: quantitation and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61: 1659–1665.
11 Tsumita, T. & M. Iwanaga. 1963. Fate of injected deoxyribonucleic acid in mice. Nature 198: 1088–1089.
12 Chused, T.M. et al. 1972. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin. Exp. Immunol. 12: 465–476.
13 Lo, Y.M.D. et al. 1999. Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64: 218–224.
14 Lam, N.Y.L. et al. 2003. Time course of early and late changes in plasma DNA in trauma patients. Clin. Chem. 49: 1286–1291.
15 Broderick, J.P. et al. 1992. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N. Engl. J Med. 326: 733–736.
16 Abraha, H.D. et al. 1997. Serum S-100 protein: relationship to clinical outcome in acute stroke. Ann. Clin. Biochem. 34: 366–370.
17 Rainer, T.H. et al. 2003. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin. Chem. 49: 562–569.
18 Lam, N.Y.L. et al. 2006. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 hours of symptom onset. Resuscitation 71–78.
19 Rainer, T.H. et al. 2005. Comparison of circulating plasma b-globin DNA and S-100 protein concentrations in patients with acute stroke. Abstract Syllabus of the 3rd Mediterranean Conference on Emergency Medicine 132.
20 Fournie, G.J. et al. 1995. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 91: 221–227.
21 Stroun, M. et al. 1989. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318–322.
22 Chang, C.P.Y. et al. 2003. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin. Chim. Acta. 327: 95–101.
23 Lam, N.Y.L. et al. 2005. Plasma cell-free DNA concentration and stroke mortality and morbidity. Abstracts for CNAPS IV: Fourth International Conference on Circulating Nucleic Acids in Plasma/Serum 32.
24 Fournie, G.J. et al. 1993. Plasma DNA as cell death marker in elderly patients. Gerontology 39: 215–221.

Citing Literature

Volume1075, Issue1

Circulating Nucleic Acids in Plasma and Serum IV

September 2006

Pages 271-277

Circulating Nucleic Acids and Critical Illness

Abstract

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Circulating Nucleic Acids and Critical Illness

Abstract

REFERENCES

Citing Literature

References

Related

Information